Amylyx shareholders elect Cohen, Quimi as directors; ratify Deloitte

Amylyx Pharmaceuticals, Inc.

Joshua Cohen and Daphne Quimi elected as Class III directors with ~32.6M and ~32.5M votes for, respectively.
Deloitte & Touche LLP ratified as independent auditor for FY2024 with 52,023,591 votes for, 162,947 against.
Non-binding advisory vote on NEO compensation approved: 41,211,831 for, 2,708,178 against, 38,594 abstain.
Shareholders chose 'One Year' as preferred frequency for future say-on-pay votes (38,275,989 for one year).
Broker non-votes of 8,341,537 on director elections and executive compensation proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.